India is substantially cheaper than Korea for plastic surgery — surgical fees typically run 40–60% lower. Korea has a more mature verification infrastructure: the KSPRS board registry is publicly searchable, ghost surgery protections are legislated, and KOIHA accreditation sets documented safety standards. The right choice depends on your procedure, budget, origin country, and how rigorously you can verify standards at the specific clinic you choose.
Cost: India vs Korea by Procedure
Three factors determine the true cost gap: the surgical fee, the flight cost from your home country, and the length of stay required for recovery.
On surgical fees alone, India holds a consistent 40–60% advantage across cosmetic procedures. A rhinoplasty that costs $2,500–7,000 USD in a Seoul clinic typically runs $1,500–3,500 USD in an Indian centre. The gap is real and significant — but it compresses once you add travel costs, and it disappears entirely if a complication requires a return trip.
For UK and European patients, India also carries a flight cost advantage: return fares London–Mumbai or London–Delhi run $400–600 USD versus $800–1,200 USD to Seoul. Australian and North American patients see a smaller differential, since Seoul is geographically closer or comparably distant to India’s major medical cities.
All-in cost estimates below assume a standard 7-night recovery stay, mid-range accommodation, and return economy flights from London. USD/AUD/KRW figures use an indicative FX rate; confirm rates at time of booking.
| Procedure | India surgical fee (USD) | Korea surgical fee (USD) | India all-in from UK (USD) | Korea all-in from UK (USD) |
|---|---|---|---|---|
| Rhinoplasty | $1,500–3,500 | $2,500–7,000 | $3,200–6,200 | $5,100–10,900 |
| Double eyelid surgery | $800–1,800 | $1,200–3,500 | $2,000–4,500 | $3,000–7,200 |
| Facelift | $3,000–6,000 | $5,000–12,000 | $4,700–9,700 | $7,500–16,400 |
| Breast augmentation | $2,500–5,000 | $4,000–9,000 | $4,200–8,700 | $6,500–13,400 |
| Jaw reduction (V-line) | $2,000–4,500 | $4,000–10,000 | $3,700–7,200 | $6,500–14,400 |
For longer or more complex procedures requiring 10–14 night stays, India’s accommodation cost advantage compounds — hotel and recovery house rates in Mumbai, Delhi, and Chennai are generally 30–50% lower than equivalent options in Seoul’s Gangnam district.
Regulatory and Certification Infrastructure
Korea and India both have formal regulatory frameworks for plastic surgery, but the practical architecture for patient verification differs substantially.
Korea’s system is built around the 대한성형외과학회 (Daehan Seonghyeong Oegwa Haghoe), the Korean Society of Plastic and Reconstructive Surgeons (KSPRS) — South Korea’s official certification and professional board for plastic and reconstructive surgeons.¹ Board certification requires six years of medical school followed by a four-year plastic surgery residency and successful passage of KSPRS board examinations.¹ As of 2024, approximately 2,100 board-certified plastic surgeons are registered with KSPRS in Korea.¹
The KSPRS public registry allows any patient to verify a surgeon’s certification by name in under two minutes.¹ KSPRS board certification is legally required to perform plastic surgery procedures in licensed Korean medical facilities — operating without it constitutes an illegal medical act.¹
Facility accreditation in Korea is overseen by KOIHA (국제의료기관인증원, Gukje Uiryo Gigwan Injeungwon — the Korean government-designated body for international patient safety accreditation).³ KOIHA standards require documented informed consent procedures, emergency response protocols, sterilization standards, qualified anesthesia personnel, and enforceable patient rights policies.³ As of 2024, approximately 350 facilities hold KOIHA accreditation, with status publicly searchable.³
India’s system is anchored by the National Medical Commission (NMC), which maintains a national medical register. NMC registration is verifiable, but it is not specialty-specific — it does not distinguish a board-certified plastic surgeon from a general practitioner performing cosmetic procedures. India’s main hospital accreditation body is NABH (National Accreditation Board for Hospitals and Healthcare Providers), which sets patient safety standards broadly comparable to KOIHA. However, NABH accreditation is less consistently held among smaller dedicated cosmetic clinics than among large hospital groups.
The practical implication: verifying a Korean surgeon’s qualifications takes two minutes. Verifying an Indian cosmetic surgeon’s specific plastic surgery training requires direct inquiry to the institution and cross-referencing with the Association of Plastic Surgeons of India (APSI) — a more active due diligence step.
Safety Record and Patient Protections
No centralized international database tracks adverse event rates by country for cosmetic surgery, so direct statistical comparison is not available. What can be compared is the institutional framework each country provides for patient protection.
Ghost surgery — where the surgeon the patient consented to is substituted, without disclosure, by a different surgeon during the procedure — has been documented in Korean cosmetic clinics and prompted legislative response. Since 2023, Korea has required hospital-grade CCTV installation in operating rooms and mandated explicit consent processes designed to make undisclosed substitutions a criminal offence. India has no equivalent statutory framework specifically targeting ghost surgery in cosmetic settings — risk mitigation depends on clinic-level policy rather than legal mandate.
Facility accreditation provides a floor for safety standards. KOIHA-accredited facilities in Korea must demonstrate emergency response protocols, sterilization standards, and qualified anesthesia personnel.³ KOIHA accreditation status is publicly searchable.³ JCI (Joint Commission International) accreditation — an internationally recognized standard — is held by fewer than 20 Korean hospitals as of 2024.³ In India, NABH accreditation covers comparable ground for large hospital groups, but smaller cosmetic-only clinics may not hold formal accreditation.
Surgeon volume is a relevant safety proxy for specialized procedures. Korea’s concentration of cosmetic surgery in Gangnam-gu — which receives approximately 60% of aesthetic medical tourists² — means high-volume surgeons performing hundreds of procedures annually are clustered in an accessible district. India’s cosmetic surgery expertise is more geographically dispersed across Mumbai, Delhi, Bengaluru, and Chennai, with fewer dedicated cosmetic-only centres at comparable volume.
For both countries, the safety calculus reduces to the same question: can you verify the specific surgeon and facility you are choosing? Korea’s infrastructure makes that verification faster and more standardized. India’s infrastructure requires more active investigation — but the investigation is achievable with the right steps.
Decision Framework: When India or Korea Makes Sense
Often a good candidate
- Korea: Patients prioritising fast, standardised surgeon verification — KSPRS certification is searchable in under two minutes via the public registry
- Korea: Patients pursuing highly specialised Korean procedures — facial contouring (jaw reduction, zygoma reduction), incisional double eyelid technique — where Korean surgeons have the highest documented case volumes
- Korea: Patients from Australia or North America where the flight time to Korea is comparable to or shorter than flights to major Indian medical cities
- Korea: Patients combining multiple Korean-specialised procedures in one trip, where Gangnam-gu's concentration of clinics reduces logistics complexity
- India: Patients from the UK or Europe where India's flight cost and time advantage (7–9 hours, $400–600 return) materially reduces all-in cost versus Korea (11–12 hours, $800–1,200 return)
- India: Patients on tighter budgets where 40–60% lower surgical fees represent a decisive factor and who have capacity for rigorous independent due diligence on surgeon credentials
- India: Patients pursuing reconstructive plastic surgery or complex maxillofacial procedures — India has deep tertiary hospital infrastructure and surgical expertise in reconstructive work
Should reconsider or wait
- Patients who cannot independently verify the specific named surgeon performing their procedure — in either country, inability to confirm credentials is a reason to pause, not proceed
- Patients with complex medical histories (cardiovascular conditions, clotting disorders, diabetes) who may require high-level post-operative hospital support — confirm ICU and emergency capacity at the chosen facility before committing
- Patients considering small, non-accredited cosmetic clinics in either country that cannot provide documentation of surgeon board certification, anesthesia qualifications, and facility accreditation status
Not a suitable candidate
- Any clinic in either country that cannot provide verifiable proof of the operating surgeon's specialist qualifications before booking
- Any clinic that is unable to confirm, in writing, which specific surgeon will perform the procedure — relevant in both countries, and the central protection ghost surgery legislation addresses in Korea
Is plastic surgery in India as safe as in Korea?
Both countries have safe plastic surgery available — and unsafe practices available. The key difference is verification access: in Korea you can confirm a surgeon's KSPRS board certification in under two minutes via the public registry, and ghost surgery is legislated against with criminal penalties. In India, due diligence requires more effort — NMC registration is verifiable but not procedure-specific, and no equivalent ghost surgery law exists. Safety is a property of the specific clinic and surgeon you choose in either country, not of the country as a whole.
Which is cheaper — India or Korea for rhinoplasty?
India's rhinoplasty surgical fees (typically $1,500–3,500 USD) are significantly lower than Korea's ($2,500–7,000 USD). However, total trip cost depends heavily on origin: UK patients flying to India save on flights ($400–600 return vs $800–1,200 to Korea) in addition to surgical fees. For a rhinoplasty trip from London, India is typically $2,000–4,000 cheaper all-in than Korea. From Sydney or New York, the gap narrows to $1,000–2,500.
Can I get facial contouring (jaw reduction, V-line) surgery in India?
Facial contouring surgery (jaw reduction, zygoma reduction, V-line) is available in India, but case volume is much lower than in Korea. These procedures are niche globally — Korea performs them at a volume that produces genuine specialization, with surgeons who have completed hundreds of jaw reductions and understand anatomical variations, nerve risks, and revision cases. For highly Korea-specific procedures, the case-volume argument for Korea is strongest.
References
¹ Korean Society of Plastic and Reconstructive Surgeons — Board Certification Registry. https://www.plasticsurgery.or.kr/
² KHIDI — Korea Health Industry Development Institute, Medical Tourism Statistics 2024. https://www.khidi.or.kr/board/DRD?pageNum=1&rowSize=10&no1=&linkId=48893782&menuId=MENU01789&maxIndex=00488937820&minIndex=00488893350&schType=0&schText=&boardStyle=&categoryId=&continent=&country=
³ Korean Accreditation for Healthcare Facilities (KAHF) and KOIHA — Standards. https://www.kahf.or.kr/